Muscarinic Acetylcholine Receptor Market Size Forecast to Reach $1.89 Billion by 2026

Jul 17, 2021

Increasing Prevalence of Disease Such as Chronic Obstructive Pulmonary Disease and Increasing Importance of Muscarinic Acetylcholine Disease Therapeutics Are the Major Factors Driving the Growth of the Market.

Hyderabad, India - July 17, 2021 /MarketersMedia/ —

Muscarinic Acetylcholine Receptor Market size is forecast to reach $1.89 billion by 2026, growing at a CAGR of 4.1% during the forecast period 2021-2026. Muscarinic Acetylcholine Receptor are kind of receptors that are involved in regulating the number of peripheral and central functions and are able to inhibit postsynaptic neurons. They are responsible for mediating the effects basically the physiological effects of the nerve activity that are parasympathetic. It has both inhibitory as well as excitatory effects that can block or stimulate the response and is stored in the acetylcholine producing neurons as cholinergic neurons. It is an ester of acetic acid and choline that functions to transmit nerve impulses within the peripheral and central nervous systems. Increasing prevalence of disease such as chronic obstructive pulmonary disease and increasing importance of muscarinic acetylcholine disease therapeutics are the major factors driving the growth of the market. Growth in research in muscarinic acetylcholine and rise in the adoption of muscarinic acetylcholine receptor is set to further enhance the overall market development of the Muscarinic Acetylcholine Receptor Market for the period 2021-2026.

Muscarinic Acetylcholine Receptor Market Segment Analysis – By Product

Tropicamide held the largest share in the Muscarinic Acetylcholine Receptor Market in 2020 and is estimated to grow at a CAGR of 4.4% during the forecast period 2021-2026. Tropicamide is a muscarinic antagonist having similar actions to atropine with an anticholinergic property. It binds the muscarinic receptors in the ciliary muscle in the eye and in the sphincter. It inhibits the responses from stimulation and produces the dilation of the pupil along with the paralysis of the ciliary muscle. Tropicamide is a diagnostic agent that is used to produce short duration cycloplegia and mydriasis. Owing to the short duration of the effect, it is used during dilated fundus examination. Cycloplegic drops are used to treat uveitis that decreases the risk of synechiae and decreases the inflammation in the anterior chamber of the eye. Tropicamide are estimated to register the higher CAGR over the period 2021-2026.

Request for Sample Report @ https://www.industryarc.com/pdfdownload.php?id=507041
Report Price: $ 5900 (Single User License)

Muscarinic Acetylcholine Receptor Market Segment Analysis – By Application

Chronic Obstructive Pulmonary Disease held the largest share in the Muscarinic Acetylcholine Receptor Market in 2020 and is estimated to grow at a CAGR of 4.3% during the forecast period 2021-2026. Muscarinic acetylcholine receptor controls smooth muscle tone, inflammation, and mucus secretion in healthy lungs. Cholinergic mechanisms contribute to increase mucus secretion and bronochoconstriction in chronic obstructive pulmonary disease. Muscarinic acetylcholine is not a neurotransmitter but it transcends the parasympathetic nervous system that can modify the phenotypic function of airway cells including the epithelial cells. Chronic Obstructive Pulmonary Disease are estimated to register the higher CAGR over the period 2021-2026.

Muscarinic Acetylcholine Receptor Market Segment Analysis – By Geography

North America dominated the Muscarinic Acetylcholine Receptor Market with a major share of 41.8% in 2020. This is attributed to the increasing number of key players that are focusing on developing mAChR for the treatment of Alzeheimers’s disease and increasing number of pharmaceutical companies that are working on new therapies for neurological conditions. Increasing incidences of chronic obstructive pulmonary disease and increased research activity for therapeutic contribution of these receptors are also increasing the growth of the market in this region.

Muscarinic Acetylcholine Receptor Market Drivers

Increasing Prevalence of Chronic Obstructive Pulmonary Disease

Increasing prevalence of chronic obstructive pulmonary disease is increasing the growth of the Muscarinic Acetylcholine Receptor Market. Chronic obstructive pulmonary disease causes obstructed airflow from the lungs which includes difficulty in breathing, mucus, and cough. It is mainly caused by long term exposure to particulate matter and irritating gases. People suffering from this have high risk of developing heart disease, and variety of other conditions. Two most common conditions that contribute to it are Emphysema and chronic bronchitis which usually occurs together. It affects 2 to 8% of the population. Thus, increasing the growth of the Muscarinic Acetylcholine Receptor Market during the forecast period 2021-2026.

Rising Awareness About Muscarinic Acetylcholine Receptor

Rising awareness about muscarinic acetylcholine receptor is increasing the growth of the Muscarinic Acetylcholine Receptor Market. Neurotransmitter acetylcholine recognized by muscarinic receptors that translates into electrical transients and altered cell behavior by suppressing the signaling pathways.

Inquiry Before Buying @ https://www.industryarc.com/reports/request-quote?id=507041

Muscarinic Acetylcholine Receptor Market Challenges

Inadequate funding and high cost involved in the treatment of the diseases

Some of the factors that are set to impede the growth of the Muscarinic Acetylcholine Receptor Market are inadequate funding and high cost involved in the treatment of the disease. Strict approval process is also set to hinder the growth of the market.

Muscarinic Acetylcholine Receptor Market Landscape

Muscarinic Acetylcholine Receptor Market, top 10 companies are Heptares Therapeutics Ltd., Astrazeneca Plc, Karuna Pharmaceuticals Inc., Anavex Life Sciences Corp., NeuroHealing Pharmaceuticals Inc. and Sumitomo Dainippon Pharma Co. Ltd. among others.

Key Takeaways

North America dominated the Muscarinic Acetylcholine Receptor Market in 2020 owing to the increasing number of key players who are continuously focusing on developing M1 mAchR agonists for treating Alzheimer’s disease and increasing number of pharmaceutical companies that are working on new therapies for rare neurological conditions. The Muscarinic Acetylcholine Receptor Market scope for different regions will be provided in the final report.

Growing public awareness and technological advancements along with rising awareness about muscarinic acetylcholine & its prevention are likely to aid the market growth of the Muscarinic Acetylcholine Receptor Market report.

Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Muscarinic Acetylcholine Receptor Market report.

Inadequate funding and high cost involved in the treatment of the diseases is poised to create the hurdles for the Muscarinic Acetylcholine Receptor Market.

Related Reports :

A. Proteinuria Treatment Market
https://www.industryarc.com/Report/16208/proteinuria-treatment-market.html

B. Hydroxytryptamine Receptor Market
https://www.industryarc.com/Research/Hydroxytryptamine-Receptor-Market-Research-502818

For more Lifesciences and Healthcare Market reports, please click here

About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.

Contact Info:
Name: Venkat Reddy
Email: Send Email
Organization: IndustryARC
Phone: (+1) 970-236-3677
Website: https://www.industryarc.com/

Source URL: https://marketersmedia.com/muscarinic-acetylcholine-receptor-market-size-forecast-to-reach-189-billion-by-2026/89036765

Source: MarketersMedia

Release ID: 89036765

Yulo: ‘We will come back stronger’

FOLLOWING a medal-less campaign at the 2026 FIG Artistic Gymnastics World Championships in Rotterdam, two-time Olympic champion Carlos Yulo said that he and his younger brother Eldrew will come back stronger next season. “By God’s grace, we’ll come back stronger. Always for the Philippines,” Yulo wrote as a finisher to a lengthy Instagram post Monday night. In the same post, Yulo said he remains grateful despite not getting the results he wanted in Rotterdam. “It wasn’t the result I hoped to give, but I’m always grateful to our Lord for giving me this opportunity — not just to compete, but also to learn, grow, and see the bigger picture,” said Yulo. “Sometimes, God allows things to happen for reasons we may not immediately understand, and I’m learning to trust His plans even more,” he added. Yulo won World Championship gold medals in floor exercise in 2019, and vault in 2021 and 2025 but placed eighth in floor exercise and seventh in vault this year. Eldrew and another Filipino gymnast Miguel Besana failed to make the medal rounds in any of the disciplines. Yulo was particularly happy that he and his siblings Eldrew and Joryeng were together in Rotterdam. He said he is proud of Eldrew and Joryeng, who was there as a judge. “I’m so happy that, despite everything that has happened, we’re still here as siblings, supporting and standing by each other. We still don’t have a picture together at the arena, though,” he said. Yulo also thanked his fiancé, Chloe San Jose, for leading the way to their Paris trip after the World Championships. For his social media post, Yulo used a photo of him, Chloe, Eldrew and Joryeng posing with the Eiffel Tower as backdrop. “Lastly, to our family back in the Philippines and everyone else who prayed for us, believed in us and supported us through it all, thank you so much,” said Yulo. “This competition may not have ended the way I wanted, but I’m choosing to be grateful for the lessons, the memories and the people God continue to bless me with. We may fall short of the results we dream of, but we will never stop fighting, learning and believing.”

Oct 27, 2026

Bolick paces race for Best Player of Conference

Oct 27, 2026

Barefield to stay with Blackwater

Oct 27, 2026

Brewers rout Rays to reach brink of World Series sweep

ST. PETERSBURG, Florida — With a devastating 16-hit batting performance and masterful pitching by Robert Gasser, the Milwaukee Brewers routed Tampa Bay, 10-1, on Monday (Tuesday in Manila), reaching the brink of a World Series sweep. Left-handed starter Gasser threw six shutout innings, allowing only one hit with a walk and three strikeouts in facing the minimum 18 batters. “It was awesome,” Gasser said. “We’re going to enjoy tonight. It was a great team win. But we’ve got work to do.” Jackson Chourio, a 22-year-old Venezuelan outfielder, went 4-for-5 at the plate, scored twice, stole a base and also drove in a run in the Brewers’ historic eight-run fifth inning to humble the Rays. All eight runs came with two outs in the inning, a World Series record, and Milwaukee batters made seven consecutive hits, a playoff first. “It was special for sure,” Chourio said through a translator. “We’ve been preparing for this day. We’ve known it was coming. We have one more to lock in for tomorrow to complete the mission.” The Brewers seized a 3-0 lead in Major League Baseball’s best-of-seven final and can win the first title in team history with a triumph in Game 4 on Tuesday at Tropicana Field. “There’s still one more game to go for us to win,” Gasser said. “I know everybody is eager to do it, and we’re going to show up tomorrow ready to go.” Gasser became the first lefty to face the minimum over six innings in a World Series clash since Sandy Koufax of the Los Angeles Dodgers in 1965. The Rays managed a run in the ninth but only three hits in the game. Chourio raced home from second base on a Christian Yelich single in the third inning to score the first run and William Contreras drove in another with a hit to right field for a 2-0 lead. The Brewers, whose only prior World Series was a 1982 loss to St. Louis in seven games, had two one-run wins to start the Series but overwhelmed Tampa Bay with a barrage in the fifth. Chourio singled, stole second and advanced to third on a Contreras single that loaded the bases as Rays starter Freddy Peralta, who had played for Milwaukee the past eight seasons, was lifted for relief pitcher Cam Booser. Brice Turang followed with a two-run single up the middle, Garrett Mitchell added a single to score Contreras, and Cooper Pratt followed with a two-run double to left field for a 7-0 Brewers lead. Sal Frelick doubled in Pratt for an 8-0 Milwaukee edge, bringing on Rays reliever Cole Sulser, who promptly surrendered a single to David Hamilton to drive in Frelick for a 9-0 lead. Chourio concluded the stunning streak with a double to right field to score Hamilton for a 10-0 Brewers lead. Gasser, meanwhile, had to wait for an extra 45 minutes before returning to the mound, watching the amazing streak with glee. “It was special. I had a smile on my face the whole time,” Gasser said. “It was just surreal when something like that happens.” Chourio’s eight hits through three games are the second-most in World Series history after nine by Billy Hatcher for Cincinnati in 1990. “My mentality is to stay on top of the ball and hit line drives,” Chourio said. “I consider myself more of a hitter than a home run hitter.” Chourio became the youngest player to ever begin a World Series with three multi-hit games, delivering singles in the first, third and fifth innings on Monday. AFP

Oct 27, 2026

Cavs edge Timberwolves in overtime

LOS ANGELES, California — The Cleveland Cavaliers ended the Minnesota Timberwolves’ perfect start to the NBA season, winning 127-125 in an overtime thriller despite 47 points from Anthony Edwards. Donovan Mitchell and James Harden led the scoring for the victorious Cavs, with 26 and 19 points apiece, as Cleveland moved to 2-1. “Tough win for us, especially early in the season,” said Harden, who added four rebounds and nine assists. The Timberwolves, having won their opening three games, led for much of the night, with a 15-point advantage in the first half. Edwards, only cleared to play late after being listed as questionable with a right knee injury, had made an electric start, with 11 points in the first quarter. But the Cavaliers rallied to pull level in the third quarter, and then had to come from behind again after slipping to a seven-point deficit in the fourth. Harden’s driving floater with 10 seconds remaining tied the game, and a blocked Edwards layup with four seconds left sent it to overtime at 113-113. With just a minute left in overtime, Edwards tied the game again with a trey so close to the arc that a video replay was required. But Mitchell reestablished Cleveland’s lead with a go-ahead midrange jumper, and when Minnesota’s Jonathan Kuminga missed a free throw with 30 seconds left, the Cavaliers pulled clear. Harden made two more free throws, leaving the Timberwolves requiring three points, but Edwards’ clutch effort bounced off the rim. Peyton Watson poured in two more free throws for Cleveland to bury the contest. “We made a lot of mistakes on both ends of the basketball in that first half... second half, we did a better job,” said Harden. Elsewhere, the Oklahoma City Thunder improved to 4-0 with a hard-fought 125-114 win over the Phoenix Suns. Ajay Mitchell led the scoring with a career-high 30, supported by Shai Gilgeous-Alexander, who added 26. “This league is about winning games, and that’s all that matters,” said Gilgeous-Alexander. “We were just ready to go. Guys were ready to go. Guys were ready to step up,” added the reigning NBA Most Valuable Player. Perfect night The Houston Rockets also stayed perfect with a 120-110 win over the Atlanta Hawks. It is their first 4-0 start since 2014, with star Kevin Durant rested for the entire fourth quarter in an ultimately comfortable win. Giannis Antetokounmpo recorded his first triple-double with new team Miami even as the Heat (0-4) suffered a 113-109 loss to the Dallas Mavericks. Antetokounmpo, a two-time league Most Valuable Player who left the Milwaukee Bucks this summer, scored 29 points with 14 rebounds and 11 assists. Mavericks teen star Cooper Flagg also scored 29, with 11 assists, six rebounds and a career-high five steals. The Grizzlies also improved to 4-0 with a 110-105 win over the Utah Jazz, while Brandon Miller scored 39 points as the Charlotte Hornets beat the Washington Wizards, 110-103. And the Golden State Warriors earned their first victory of the season with a 134-114 triumph over the Denver Nuggets. Stephen Curry made 8-of-8 field goal attempts for 24 points. “Just staying patient. We’ve been working on some offensive approach where I know I get a lot of attention, trying not to force things,” he said. “I didn’t know it was going to be a perfect night like that, but glad it all came together.”